Device / Technology News

RSS

SequelMed Patient Portal launched by Sequel Systems

Sequel Systems, Inc., a dynamic, service-oriented healthcare technology company, today announced the launch and general availability of SequelMed Patient Portal™, a new, Web-based tool that improves and speeds up communication between physicians and patients, giving patients instant access to their personal health information, and allowing physicians and other healthcare providers more time to focus on delivering the best possible care. SequelMed Patient Portal is the latest addition to Sequel Systems’ suite of healthcare solutions, which includes an electronic health record (EHR), practice and document management software, and e-prescribing technology. More than 12,000 physicians in all 50 states and representing all major specialties currently use the company’s solutions.

19 Oct 2009

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

Alcohol and drug use are known contributors to adolescents engaging in dangerous sexual activity; leading to substantial health risks such as unwanted pregnancies, sexually transmitted illnesses, drug overdoses and alcohol poisonings. Yet, research suggests that fewer than half of pediatricians report screening patients for substance use and at-risk sexual behavior.

19 Oct 2009

FDA approves Quotient Biodiagnostics' BLA for transfusion diagnostic monoclonal antibodies

Quotient Biodiagnostics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved its biologics license application (BLA) for the first 15 monoclonal antibodies in its proprietary line of transfusion diagnostics. These products are for use by blood donor centers, reference laboratories, and hospitals to type and screen blood.

19 Oct 2009

GenoLogics and CLC bio to provide end-to-end informatics solution for workflow management

GenoLogics and CLC bio today announced they will provide an end-to-end informatics and analysis solution, optimized for Next Generation Sequencing research that addresses both lab and data management and data analysis all within one integrated system.

19 Oct 2009

Oral salmon calcitonin using absorption-enhancing Eligen Technology holds promise for osteoarthritis

Emisphere Technologies, Inc. announced study results in which twice-daily oral salmon calcitonin using Emisphere’s proprietary Eligen® Drug Delivery Technology significantly suppressed markers of cartilage and bone degradation versus placebo in men and women with osteoarthritis, the most common form of arthritis.

19 Oct 2009

Chinese SFDA approves China Medical Technologies' SPR System

China Medical Technologies, Inc., a leading China-based medical device company that develops, manufactures and markets advanced in-vitro diagnostic products, today announced that the Company has received approval for its SPR- based analysis system (the "SPR System") from the State Food and Drug Administration of China (the "SFDA").

19 Oct 2009

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

Premier Plastic Surgery of Kansas City, serving residents of Kansas City and beyond for 22 years, has redesigned its extensive website to include a separate section on Cosmetic Surgery for Males, a new Skin Care Centre, and a Plastic Surgery Blog that features breaking news on emerging research, techniques and products.

19 Oct 2009

New decision-making tool offers breast reconstruction options post cancer surgery

A computer-based decision-making aid may make it possible for more women to have breast reconstruction after surgical treatment for cancer.

19 Oct 2009

QLT receives exclusive U.S. sales and marketing rights for Visudyne therapy

QLT Inc. ("QLT" or the "Company") today announced that it has restructured its agreement with Novartis Pharma AG ("Novartis") to simplify the relationship, under which, effective January 1, 2010, it will, among other things, receive exclusive U.S. rights to the Visudyne(R) patents to sell and market Visudyne in the U.S. Visudyne, a photosensitizer co-developed with Novartis, is approved worldwide for the treatment of a form of wet age-related macular degeneration ("AMD"), the leading cause of legal blindness in people over the age of 55 in North America and Europe.

19 Oct 2009

New tool developed to easily place assisted breathing devices under difficult circumstances

A new tool developed by a Medical College of Georgia resident and faculty member may make it easier to place assisted breathing devices under difficult circumstances.

19 Oct 2009

New 3D scaffolding technology may help grow skin and blood vessels in labs

Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).

19 Oct 2009

First high-throughput analysis of Salmonella Typhi gene

For the first time, researchers are able to look at the need for every gene in a bacterial cell in a single experiment. The new method will transform the study of gene activity and the search for weaknesses in bacterial armouries.

19 Oct 2009

New mathematical model for rapid and accurate diagnoses of AHF

Researchers at St. Michael's Hospital have developed the first mathematical model in cardiology and emergency medicine to more quickly and reliably diagnose acute heart failure (AHF) in emergency room patients

19 Oct 2009

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

Evolutionary Systems, (Evosys) a leading systems integrator for the healthcare and public sector industry, has been awarded Oracle's Certified Advantage Partner status by Oracle. To achieve this accreditation Evosys underwent a number of rigorous assessments, covering technical excellence, commercial capability and customer satisfaction.

19 Oct 2009

TheraDoc commences beta testing of new computerized patient surveillance tool

TheraDoc®, the leading provider of clinical decision support technology in healthcare, today announced that it has started beta testing of a new computerized patient surveillance tool that will help hospitals monitor and manage screening programs for multidrug-resistant organisms (MDROs), such as methicillin-resistant Staphylococcus aureus, or MRSA, which every year kills more people in the United States than AIDS.

19 Oct 2009

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

The U.S. Food and Drug Administration (FDA) today issued a second emergency use authorization (EUA) to Focus Diagnostics, the infectious disease diagnostics business of Quest Diagnostics Incorporated, for its 2009 H1N1 influenza virus test. With the EUA, Focus Diagnostics is the only company in the U.S. to offer test kits for detecting the pandemic 2009 H1N1 virus that the FDA has authorized for emergency use by CLIA high-complexity labs, which include certain hospital and regional labs.

19 Oct 2009

Palomar Medical Technologies to continue commercialization of its wrinkle treatment laser device

Palomar Medical Technologies Inc., a leading researcher and developer of light-based systems for cosmetic treatments, today announced the termination of its agreement with Johnson & Johnson Consumer Companies Inc ("JJCC"), a Johnson & Johnson company, to develop, clinically test and commercialize home-use, light-based devices for (i) reducing or reshaping body fat including cellulite; (ii) reducing appearance of skin aging; and (iii) reducing or preventing acne.

19 Oct 2009

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

The National Institutes of Health announced today that it is awarding 15 new grants to further develop and test the Patient Reported Outcomes Measurement Information System (PROMIS).

19 Oct 2009

Olympus unveils new surgical instruments for single-incision procedures

Olympus, a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today introduced three new surgical instruments specifically designed for Laparo-Endoscopic Single-Site (LESS) surgery

From Evident Corporation - Life Sciences 19 Oct 2009

$FRAX online tool to help clinicians to better identify women and men at high risk of fracture$

FRAX online tool to help clinicians to better identify women and men at high risk of fracture

The International Osteoporosis Foundation (IOF) will issue a new 16-page report on FRAX- to mark World Osteoporosis Day on October 20, 2009. The report is available at http://www.iofbonehealth.org/publications/frax.html

19 Oct 2009

Device / Technology News

SequelMed Patient Portal launched by Sequel Systems

Children's Hospital Boston's CRAFFT substance abuse diagnostic test helps identify high risk sexual behavior

FDA approves Quotient Biodiagnostics' BLA for transfusion diagnostic monoclonal antibodies

GenoLogics and CLC bio to provide end-to-end informatics solution for workflow management

Oral salmon calcitonin using absorption-enhancing Eligen Technology holds promise for osteoarthritis

Chinese SFDA approves China Medical Technologies' SPR System

Premier Plastic Surgery redesigns its website to provide more information of cosmetic surgery

New decision-making tool offers breast reconstruction options post cancer surgery

QLT receives exclusive U.S. sales and marketing rights for Visudyne therapy

New tool developed to easily place assisted breathing devices under difficult circumstances

New 3D scaffolding technology may help grow skin and blood vessels in labs

First high-throughput analysis of Salmonella Typhi gene

New mathematical model for rapid and accurate diagnoses of AHF

Healthcare systems integrator Evolutionary Systems awarded Oracle's Certified Advantage Partner status

TheraDoc commences beta testing of new computerized patient surveillance tool

Focus Diagnostics' 2009 H1N1 influenza virus test granted FDA emergency use authorization

Palomar Medical Technologies to continue commercialization of its wrinkle treatment laser device

New NIH grants to develop Patient-Reported Outcomes Measurement Information System

Olympus unveils new surgical instruments for single-incision procedures

FRAX online tool to help clinicians to better identify women and men at high risk of fracture

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News